ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

@flyers,

I am hoping that the 10K will NOT disclose any futher dilution, especially from new issuances of restricted stock, but I just can't come up with any other way that SCRC could have come up with so much cash on hand during Q4, especially since we all know that their new revenue stream re: the NJ compounding pharmacy did not come online until FEB-2014 (on top of the fact that we have no clue what SCRC's cut is nor what the margins are) and that their other existing revenue streams are not even cash-flow positive yet.

I had previously opined in a post a while back close to the time when the PR came out announcing "No new notes since 10/23/13" that unregistered private sales of restricted stock appeared to be the logical explanation and had theorized that based upon the current sp at the time that a very steep discount would have been likely -- one that would translate to a restricted stock sale of approx .05/share. This was my educated guess -- and hopefully it would be the worst case scenario -- as to the price that would make it attractive enough for private investors to accept the deal.

This is why I am very eager to see the 10K disclosures as I want to put these dilution concerns to bed one way or the other. Again, I hope my theory ends up being unfounded.